Anifrolumab: the new frontier in the treatment of genetic interferonopathies
Christophe Richez,
Marie-Louise Frémond,
Clemence David
Affiliations
Christophe Richez
38Rheumatology Department, FHU ACRONIM, Pellegrin Hospital and UMR CNRS 5164, Bordeaux University, Bordeaux, France
Marie-Louise Frémond
Department of Paediatric Hematology-Immunology and Rheumatology, Centre de Référence des Rhumatismes inflammatoires, maladies Auto-immunes et Interféronopathies Systémiques de l`Enfant RAISE, Necker-Enfants Malades Hospital, AP-HP, Paris, France
Clemence David
Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France
